GENE ONLINE|News &
Opinion
Blog

2020-08-26| COVID-19Special

USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy

by Pavel Ryzhov
Share To
Following backlash from critics, FDA chief Stephen Hahn apologized for his remarks that were in agreement with the US President Donald Trump’s claim that convalescent plasma is a powerful therapy for COVID-19. The race against the clock to find a safe and efficacious treatment option against COVID-19 has been ongoing for the last 9 months. The difficulty lies not only in finding the appropriate medical intervention

GO Prime with only $1.49 now

LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!